Twenty bis-5-methylbenzimidazole compounds were evaluated for their in vitro antifungal activity against Candida albicans and Candida tropicalis. Except for three all compounds exhibited an antifungal activity against these yeasts over a range of the minimum inhibitory concentration (MIC) between 25 and 800 mg/L.

Department of Chemistry Faculty of Arts and Sciences Inönü University 44069 Malatya Turkey

See more in PubMed

Folia Microbiol (Praha). 2002;47(5):481-7 PubMed

Arzneimittelforschung. 1992 Aug;42(8):1045-8 PubMed

Arzneimittelforschung. 1996 Aug;46(8):821-3 PubMed

Antimicrob Agents Chemother. 1998 Mar;42(3):666-74 PubMed

Antimicrob Agents Chemother. 1998 Oct;42(10):2495-502 PubMed

Folia Microbiol (Praha). 2002;47(1):29-31 PubMed

Arzneimittelforschung. 2001;51(5):420-4 PubMed

Arzneimittelforschung. 2004;54(1):64-8 PubMed

Arzneimittelforschung. 1997 May;47(5):667-70 PubMed

Antimicrobial activity of ZnII, CdII, and HgII complexes of 1,2-bis-[2-(5-R)-1H-benzimidazolyl]-1,2-ethanediols and 1,4-bis-[2-(5-R)-1H-benzimidazolyl]-1,2,3,4-butanetetraols

Antimicrobial activity of 1,2-bis-[2-(5-R)-1H-benzimidazolyl]- 1,2-ethanediols, 1,4-bis-[2-(5-R)-1H-benzimidazolyl]- 1,2,3,4-butanetetraols and their FeIII, CuII, and AgI complexes